Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam vs oxycodone in postoperative IV PCA after general surgery
KCT0003896Phase 3Recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nefopam, oxycodone in acute postoperative pain, postoperative nausea and vomiting (PONV), sponsored by Pharmbio Korea Inc.. Started Dec 2016; status: recruiting.
02
Drugs
nefopamoxycodone
03
Conditions
acute postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on KCT0003896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003896.